Agios Pharmaceuticals AGIO
NASDAQ AGIO
$33.10 -0.03 (-0.09%)
As of: Sep 4, 2026 · 3:59 PM EDT

Agios Pharmaceuticals (AGIO) Preferred Shares (2012 - 2013)

Agios Pharmaceuticals' (AGIO) quarterly Preferred Shares came in at $5.7 million in Q3 2013, down 92.63% on a QoQ basis from $77.3 million in Q2 2013.

Analysis

Agios Pharmaceuticals (AGIO) Preferred Shares (2012 - 2013) Analysis & Trends

Agios Pharmaceuticals (AGIO) has 2 years of Preferred Shares data on file, last reported at $5.7 million in Q3 2013.

  • Quarterly Preferred Shares changed N/A year-over-year to $5.7 million in Q3 2013, while the trailing twelve-month figure through Sep 2013 was $5.7 million (changed N/A YoY) and the FY2012 annual result came in at $77.3 million, changed N/A from the prior year.
  • Preferred Shares declined to $5.7 million in Q3 2013, from $77.3 million in the prior quarter.
  • In the past five years, Preferred Shares ranged from a high of $77.3 million in Q4 2012 to a low of $5.7 million in Q3 2013.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn -
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn -
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn -
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn -
10 Agios Pharmaceuticals 1.97 Bn 1.97 Bn 41.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2013 5.70 Mn
Jun 30, 2013 77.30 Mn
Dec 31, 2012 77.30 Mn